Harrow (HROW) stock plunged 20% post-market after the eye care drugmaker’s Q3 earnings report missed Street estimates on the ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an innovative initiative to ...

GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...

On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...

Raymond James has recently raised Goodrx Holdings Inc (GDRX) stock to Strong Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 23, 2024, RBC Capital Mkts had raised the ...

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on GoodRx Holdings (GDRX – Research Report), with a ...

Over the past few days, the news from GoodRx Holdings (NASDAQ: GDRX) hasn't been all that good. On Thursday the online ...

GoodRx Holdings Inc (GDRX) reports robust growth in adjusted EBITDA and Pharma Manufacturer Solutions revenue, despite facing ...